PubRank

Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet (S-LITE)

Clinical Trial ID NCT04122716

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04122716

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000 70.59
2 A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med 2015 11.05
3 Long-term weight loss maintenance. Am J Clin Nutr 2005 7.42
4 Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. START INVESTS P 13. N Engl J Med 2016 7.04
5 Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995 7.03
6 American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009 6.07
7 Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2016 5.87
8 Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003 5.43
9 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2013 5.02
10 Exercise for overweight or obesity. Cochrane Database Syst Rev 2006 4.41
11 Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006 4.19
12 Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 2001 3.81
13 Effect of exercise on 24-month weight loss maintenance in overweight women. Arch Intern Med 2008 3.61
14 Long-term weight loss after diet and exercise: a systematic review. Int J Obes (Lond) 2005 3.42
15 Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998 3.18
16 The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011 2.77
17 High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002 2.36
18 Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Diabetes 2010 2.34
19 Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 2003 2.31
20 The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 2005 2.18
21 The role of diet and exercise for the maintenance of fat-free mass and resting metabolic rate during weight loss. Sports Med 2006 1.92
22 Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 2006 1.80
23 Maintenance of weight loss after lifestyle interventions for overweight and obesity, a systematic review. Obes Rev 2010 1.80
24 Adaptive thermogenesis in humans. Int J Obes (Lond) 2010 1.69
25 Exercise and the metabolic syndrome with weight regain. J Appl Physiol (1985) 2010 1.66
26 Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial. JAMA 2015 1.56
27 The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis 2013 1.48
28 Glucagon-like peptide-1, glucose homeostasis and diabetes. Trends Mol Med 2008 1.46
29 A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity. Circulation 2012 1.39
30 Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. Int J Obes (Lond) 2013 1.39
31 Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab 2011 1.37
32 Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition. Diabetes Care 2010 1.21
33 Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circ Res 2015 1.20
34 Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia 2012 1.16
35 Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. Cell Metab 2016 1.09
36 Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms. Sports Med 2013 1.04
37 Endurance training per se increases metabolic health in young, moderately overweight men. Obesity (Silver Spring) 2012 0.92
38 Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus. Diabetologia 2013 0.87
39 AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. Endocr Pract 2016 0.86
40 Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study. Lipids Health Dis 2014 0.85
41 Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss. Int J Obes (Lond) 2014 0.85
42 Impact of weight regain on metabolic disease risk: a review of human trials. J Obes 2014 0.81
43 Impact of weight loss with or without exercise on abdominal fat and insulin resistance in obese individuals: a randomised clinical trial. Br J Nutr 2013 0.80
44 Effects of matched weight loss from calorie restriction, exercise, or both on cardiovascular disease risk factors: a randomized intervention trial. Am J Clin Nutr 2016 0.80
45 Morbidity and mortality associated with obesity. Ann Transl Med 2017 0.76
46 Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36. Eur J Endocrinol 2016 0.76
47 Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity. Endocrine 2016 0.75
48 GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction. Clin Sci (Lond) 2017 0.75
49 Exercise Preserves Lean Mass and Performance during Severe Energy Deficit: The Role of Exercise Volume and Dietary Protein Content. Front Physiol 2017 0.75
50 Glucagon and glucagon-like peptide-1 as novel anti-inflammatory and immunomodulatory compounds. Eur J Pharmacol 2017 0.75
Next 100